Octagon Capital Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
|
|||||
|
2025
Q1 | $14.9M | Buy |
|
|||||
|
2024
Q4 | $18.1M | Buy |
|
|||||
|
2024
Q3 | $9.19M | Hold |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $8.7M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $8.78M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $6.79M | Hold |
|
|||||
|
2021
Q1 | $6.5M | Hold |
|
|||||
|
2020
Q4 | $8.5M | Buy |
|